Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM3 | Q14832 | 2/20 | 1.00 |
| ▸ | FOLH1 | Q04609 | 7/20 | 0.77 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5060080 | 0.92 | GRM3 (0.85) | GRM3FOLH1NAALAD2 | |
| SCHEMBL4143572 | 0.91 | GRM3 (0.82) | GRM3FOLH1NAALAD2 | |
| SCHEMBL5060255 | 0.91 | GRM3 (0.82) | GRM3FOLH1NAALAD2 | |
| SCHEMBL18647063 | 0.91 | GRM3 (0.82) | GRM3FOLH1NAALAD2 | |
| SCHEMBL5051325 | 0.90 | GRM3 (0.81) | GRM3FOLH1NAALAD2 | |
| SCHEMBL20529841 | 0.90 | GRM3 (0.81) | GRM3FOLH1NAALAD2 | |
| SCHEMBL5053371 | 0.89 | GRM3 (0.79) | GRM3FOLH1NAALAD2 | |
| SCHEMBL1376163 | 0.88 | GRM3 (0.79) | GRM3FOLH1NAALAD2 | |
| SCHEMBL1377500 | 0.88 | GRM3 (0.79) | GRM3FOLH1NAALAD2 | |
| SCHEMBL16528703 | 0.87 | FOLH1 (1.00) | GRM3FOLH1NAALAD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 152 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3893028-B1 | METHOD FOR SECURITY INSPECTION AND KIT OF PARTS WITH A DETACHABLE SINGLE-USE INLAY FOR AN X-RAY TRAY | GONZALEZ MARIN SARAY (DE) | 2025-06-04 | — | — | EP | claimed |
| CN-119977917-A | Chemically responsive crosslinking agent and preparation method and application thereof | 南开大学 | 2025-05-13 | — | — | CN | claimed |
| CN-119371639-A | Preparation method of one-dimensional graphite alkyne chain | 昆明理工大学 | 2025-01-28 | — | — | CN | claimed |
| CN-117924725-A | Crystalline semiconductor material, preparation method thereof and application thereof in radiation detection and imaging field | 闽都创新实验室 | 2024-04-26 | — | — | CN | claimed |
| CN-114805653-B | Phenyl polydiacetylenic acid and preparation method, application and recovery thereof | 常州大学 | 2023-06-20 | — | — | CN | claimed |
| CN-112812353-B | Flexible colorless transparent polyimide composite structure and preparation method thereof | 长春聚明光电材料有限公司 | 2023-04-28 | — | — | CN | claimed |
| CN-114805653-A | Phenyl polydiacetylene acid and preparation method, application and recovery thereof | 常州大学 | 2022-07-29 | — | — | CN | claimed |
| US-10730998-B2 | Bio-based thermosets | NDSU RESEARCH FOUNDATION (US) | 2020-08-04 | — | — | US | claimed |
| US-20180244834-A1 | BIO-BASED THERMOSETS | NDSU RESEARCH FOUNDATION | 2018-08-30 | — | — | US | claimed |
| WO-2017048949-A1 | BIO-BASED THERMOSETS | NDSU RESEARCH FOUNDATION (US) | 2017-03-23 | — | — | WO | claimed |
| US-12582612-B2 | Pharmaceutical composition of Siglec-binding agents | CYTODIGM, INC. (US) | 2026-03-24 | — | — | US | disclosed |
| US-20260000700-A1 | TARGETED LINEAR CONJUGATES COMPRISING POLYETHYLENEIMINE AND POLYETHYLENE GLYCOL AND POLYPLEXES COMPRISING THE SAME | TARGIMMUNE THERAPEUTICS AG (CH) | 2026-01-01 | — | — | US | disclosed |
| US-20260000771-A1 | PSMA-TARGETING LINEAR CONJUGATES COMPRISING POLYETHYLENEIMINE AND POLYETHYLENE GLYCOL AND POLYPLEXES COMPRISING THE SAME | TARGIMMUNE THERAPEUTICS AG (CH) | 2026-01-01 | — | — | US | disclosed |
| WO-2025238236-A1 | POLYPLEXES OF NUCLEIC ACIDS AND TARGETED CONJUGATES COMPRISING POLYETHYLENEIMINE AND POLYETHYLENE GLYCOL | TARGIMMUNE THERAPEUTICS AG (CH) | 2025-11-20 | — | — | WO | disclosed |
| CN-119977917-B | Chemically responsive crosslinking agent and preparation method and application thereof | 南开大学 | 2025-11-18 | — | — | CN | disclosed |
| US-20040054190-A1 | Imaging prostate cancer | JOHNS HOPKINS UNIVERSITY | 2004-03-18 | — | — | US | disclosed |
| US-20040002478-A1 | Ligands for metabotropic glutamate receptors and inhibitors of NAALADase | NIH - DEITR | 2004-01-01 | — | — | US | disclosed |
| WO-2003060523-A1 | IMAGING AGENTS AND METHODS OF IMAGING NAALADASE OF PSMA | JOHNS HOPKINS UNIVERSITY (US) | 2003-07-24 | — | — | WO | disclosed |
| US-6528499-B1 | Ligands for metabotropic glutamate receptors and inhibitors of NAALADase | GEORGETOWN UNIVERSITY | 2003-03-04 | — | — | US | disclosed |
| WO-2002022627-A2 | LIGANDS FOR METABOTROPIC GLUTAMATE RECEPTORS | GEORGETWON UNIVERSITY (US) | 2002-03-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040054190-A1 | Imaging prostate cancer | FOLH1, DUT, NAALAD2 | GRM3 3266/4885FOLH1 1/4885NAALAD2 3/4885 |
| US-20260000771-A1 | PSMA-TARGETING LINEAR CONJUGATES COMPRISING POLYETHYLENEIMINE AND POLYETHYLENE GLYCOL AND POLYPLEXES COMPRISING THE SAME | PSMA1, PSMA3, PSMA2 | GRM3 616/4885FOLH1 9/4885NAALAD2 419/4885 |
| US-20040002478-A1 | Ligands for metabotropic glutamate receptors and inhibitors of NAALADase | GRM3, GRM2, GRM1 | GRM3 1/4885FOLH1 167/4885NAALAD2 52/4885 |
| US-20260000700-A1 | TARGETED LINEAR CONJUGATES COMPRISING POLYETHYLENEIMINE AND POLYETHYLENE GLYCOL AND POLYPLEXES COMPRISING THE SAME | CTDSP1, POLM, MCTS1 | GRM3 1575/4885FOLH1 1294/4885NAALAD2 3059/4885 |
| US-12582612-B2 | Pharmaceutical composition of Siglec-binding agents | SIGLEC7, SIGLEC9, CD2 | GRM3 2802/4885FOLH1 1488/4885NAALAD2 1847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.